Skip to content
Screener

Other, net at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$588M-1,570%
Stryker logo
StrykerSYK
-$147M-2,350%
CONMED logo
CONMEDCNMD
$182K-62.3%
Vericel logo
VericelVCEL
-$23K-109%
Enovis logo
EnovisENOV
-$7.67M
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$2.2B+4.8%
Gross profit$1.5B+3.8%
Operating income$326.1M+8.7%
Net income$198.3M+29.8%
EPS (diluted)$1.03+33.8%

Balance sheet

See full
Cash & equivalents$410.0M-26.4%
Total debt$7.5B-1.2%
Total equity$12.6B+0.8%
Total assets$22.8B-0.3%

Cash flow

See full
Operating cash flow$447.8M+18.4%
CapEx$54.2M+8.2%
Free cash flow$393.6M+20.0%

Valuation

See full
Market cap$18.54B+2.8%
Enterprise value$25.61B+2.2%
P/E23×+1.1×
P/S2.2×-0.1×

Profitability

See full
Gross margin69.9%-1.2pp
Operating margin14.2%-1.9pp
Net margin9.5%-1.0pp
FCF margin17.9%-0.9pp

Returns & leverage

See full
Return on equity6.4%-0.1pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.2×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: Zimmer Biomet Holdings’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335044
Line itemFor the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Business combination contingent consideration payments(69.2)(17.4)
Debt issuance costs(1.3)(17.3)
Repurchase of common stock(500.8)(237.0)
Other financing activities(17.9)(16.1)
Net cash (used in) provided by financing activities(640.3)739.2
Effect of exchange rates on cash and cash equivalents1.121.6
Change in cash and cash equivalents(181.9)31.4
Cash and cash equivalents, beginning of year591.9525.5

Item 1. Financial Statements

FAQ

What is Zimmer Biomet Holdings's other, net?
Zimmer Biomet Holdings (ZBH) reported other, net of -$2.3M in Q2 2026.
How has Zimmer Biomet Holdings's other, net changed year-over-year?
Zimmer Biomet Holdings's other, net decreased by 155.6% year-over-year, from -$900K to -$2.3M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about Zimmer Biomet Holdings's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude